LEMAITRE VASCULAR INC (LMAT)

symbol lookup

Follow LMAT via My Validea and receive an email alert whenever any of our strategies changes its rating.

Get Started
Score: 87/100
Analysis based upon 11/17/2017 closing price.
Latest Close: $34.56 Market Cap ($ mil): $657 Sector: Healthcare Industry: Medical Equipment & Supplies Debt/Equity: 0.00
PE Ratio: 44.4 Price/Sales: 6.7 Price/Book: 6.3 Yield: 0.6% Return on Equity: 16.1%
52 Week High: $39.88 52 Week Low: $19.82 Relative Strength: 79 LT EPS Growth: 36.4% LT Sales Growth: 10.8%
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Report Card - P/E/Growth Investor

Guru Criteria: Peter Lynch  
P/E/GROWTH RATIO:PASS
SALES AND P/E RATIO:NEUTRAL
INVENTORY TO SALES:PASS
EPS GROWTH RATE:PASS
TOTAL DEBT/EQUITY RATIO:PASS
FREE CASH FLOW:NEUTRAL
NET CASH POSITION:NEUTRAL

Detailed Analysis

Get a full analysis of LMAT using this and 11 other strategies of investment legends.

Start Your Free Trial